3′3′ cyclic dinucleotides containing isonucleotidic units
AssigneeInstitute of Organic Chemistry and Biochemistry AS Cr, V. V. I.
InventorsGabriel Birkus, Milan Dejmek, Radim Nencka, Michal Sala
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to 3′3′ cyclic dinucleotides containing isonucleotidic units, their pharmaceutically acceptable salts, their pharmaceutical composition and combinations of substances and other medicaments or pharmaceuticals. The disclosure also relates to the compounds for the treatment or prevention of diseases or conditions modifiable by STING protein modulation, such as cancer or viral, allergic and inflammatory diseases. In addition, these substances can be used as adjuvants in vaccines.
Claims17
A compound of formula (J):
- or an enantiomer, hydrate, solvate, or pharmaceutically acceptable salt or addition salt thereof,
- wherein
- Y1 and Y2 are each independently —O— or —CH2—;
- X1 and X3 are each independently OH, SH, OR15, or SR15,
- X2 and X4 are each independently O or S;
- RB1 is selected from Base′ and H,
- RB2 is selected from Base′ and H,
- wherein one of RB1 and RB2 is Base′;
- R1 is H or CN or F or Cl;
- R4 is H or OH or F;
- R6 is selected from H, CN, N3, F, Cl, COOR15, CON(R15)2, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, OR15, SR15, and N(R15)2;
- each R15 is independently H, —C(═Z)R16, —C(═Z)OR16, —C(═Z)SR16, —C(═Z)N(R16)2, —CH2—Z—C(═Z)R16, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C7 cycloalkyl, C2-C10 heterocycloalkyl, C6-C10 aryl, or C2-C10 heteroaryl;
- each R16 is independently H, C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C3-C7 cycloalkyl, C2-C10 heterocycloalkyl, C6-C10 aryl, or C2-C10 heteroaryl;
- preferably each R16 is independently H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C7 cycloalkyl, C2-C10 heterocycloalkyl, C6-C10 aryl, or C2-C10 heteroaryl;
- each Z is independently O or S;
- Base′ and Base are each independently:
- wherein
- A1, A2, A3 and A4 are each independently H, OH, SH, F, Cl, Br, I, NH2, OR15, SR15, NHR15, N(R15)2, or R16, and
- wherein the C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C7 cycloalkyl, C2-C10 heterocycloalkyl, C6-C10 aryl, or C2-C10 heteroaryl independently in each instance is optionally substituted with 1, 2, or 3 substituents independently selected from —OH;
- —SH;
- —NH2;
- —O;
- ═NH;
- —S;
- halogen;
- —N3;
- C6-C10 aryl optionally substituted with 1, 2, or 3 substituents independently selected from —OH, —CN, —O(C═O)ORB, —O(C═O)RB, and —COORB;
- unsubstituted C1-C6 alkyl;
- unsubstituted C1-C6 alkoxy;
- unsubstituted C1-C6 alkylthio;
- unsubstituted C1-C6 alkylamino;
- unsubstituted C1-C6 dialkylamino;
- —CN;
- —O(C═O)ORB;
- —O(C═O)RB;
- and —COORB;
- wherein RB is H or unsubstituted C1-C6 alkyl.
The compound according to, wherein
- Base′ is and Base is
- or Base′ is and Base is
- or Base′ is and Base is
Dependencies are inferred from the claim text.